tetradecanoylphorbol acetate has been researched along with Libman-Sacks Disease in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (28.26) | 18.7374 |
1990's | 20 (43.48) | 18.2507 |
2000's | 2 (4.35) | 29.6817 |
2010's | 10 (21.74) | 24.3611 |
2020's | 1 (2.17) | 2.80 |
Authors | Studies |
---|---|
Aguilar-Ruiz, SR; Baltierez-Hoyos, R; Gómez-Bustamante, ÁE; Ríos-Ríos, WJ; Romero-Tlalolini, MLÁ; Sosa-Luis, SA; Torres-Aguilar, H | 1 |
Gillen, J; Jaroonwitchawan, T; Leelahavanichkul, A; Nita-Lazar, A; Ondee, T; Pisitkun, T; Somparn, P | 1 |
Dolff, S; Kribben, A; Scharpenberg, C; Specker, C; Wilde, B; Witzke, O | 1 |
Fitzgerald, LM; Hedrich, CM; Mizui, M; Nagpal, K; Sunahori, K; Tsokos, GC | 1 |
Casali, P; Flores-Gutiérrez, JP; Hevezi, P; Jakez-Ocampo, J; Lima, G; Llorente, L; Luu, VP; Maravillas-Montero, JL; Santos-Argumedo, L; Vences-Catalan, F; Vilches-Cisneros, N; White, CA; Zlotnik, A | 1 |
Bengtsson, AA; Gullstrand, B; Hansson, M; Hellmark, T; Johansson, ÅC; Pettersson, Å; Wichert, S | 1 |
Abdollahi, N; Ghoryani, M; Mahmoudi, M; Rastin, M; Reihani, H; Sahebari, M; Tabasi, NS; Zamani Taghizadeh Rabe, S | 1 |
de Paz, B; Gómez, J; López, P; Prado, C; Rodríguez-Carrio, J; Suárez, A | 1 |
Benedyk, K; Juang, YT; Kerkhoff, C; Kyttaris, VC; Rauen, T; Roth, J; Tenbrock, K; Tsokos, GC | 1 |
Qiao-Ling, Z; Rong, T; Xiao-xia, Z; Xiao-Zhao, L; Zhi-Chun, L; Zhi-Qin, L | 1 |
Abián, J; Callejas-Rubio, JL; Carrascal, M; García-Rodríguez, S; Lario, A; Longobardo, V; Ortego-Centeno, N; Pavón, EJ; Perandrés-López, R; Rosal-Vela, A; Sancho, J; Zubiaur, M; Zumaquero, E | 1 |
Font, J; Ingelmo, M; Martorell, J; Rojo, I; Vilella, R; Vives, J | 1 |
Bakke, AC; Gendler, S; Gillis, S; Horwitz, DA; Kitridou, RC; Linker-Israeli, M | 1 |
Alarcón-Segovia, D; Alcocer-Varela, J; Laffon, A | 1 |
Budd, RC; Clements, JL; Cooper, SM; Wolfe, J | 1 |
Chu, EB; Ernst, DN; Hobbs, MV; Weigle, WO | 1 |
Font, J; Ingelmo, M; Martorell, J; Plana, M; Viñas, O; Vives, J | 1 |
Blasini, AM; Gonzalez, F; Rodriguez, MA; Stekman, IL; Tositti, ML | 1 |
Cohen, PL; Eisenberg, RA; Shevach, EM; Sobel, ES; Yokoyama, WM | 1 |
Faried, HF; Okuda, T; Tachibana, T | 1 |
Berger, D; Crow, MK; Koshy, M | 1 |
Butfiloski, EJ; DesJardin, LE; Schiffenbauer, J; Sobel, ES | 1 |
Abud-Mendoza, C; González-Amaro, R; Portales-Pérez, D; Sánchez-Armáss, S | 1 |
Enomoto, H; Funauchi, M; Horiuchi, A; Ikoma, S | 1 |
Abdou, NI; Evans, MJ; Mitamura, K; Rider, V; Suenaga, R | 1 |
Abud-Mendoza, C; Alarcón-Segovia, D; Alcocer-Varela, J; Baranda, L; González-Amaro, R; Llorente, L; Portales-Pérez, D; Richaud-Patin, Y | 1 |
Lei, HY; Liu, HS; Liu, MF; Wang, CR | 1 |
Abel, J; Degen, G; Gleichmann, E; Goebel, C; Mittmann, S; Sachs, B; Schraa, S; Uetrecht, J; Vogel, C; Wulferink, M | 1 |
Dennis, G; Kammer, GM; Tsokos, GC; Wong, HK | 1 |
Durnev, AD; Lisitsyna, TA; Seredenin, SB; Vasil'eva, IM; Zasukhina, GD | 1 |
Antal-Szalmás, P; Gergely, P; Kiss, E; Kovács, I; Lakos, G; Sipka, S; Szántó, S; Szegedi, G; Szucs, K | 1 |
Kabarowski, JH; Le, LQ; Witte, ON; Xu, Y; Zhu, K | 1 |
Jones, SK | 1 |
Amprimo, MC; Basolo, B; Cavalli, G; Ferrero, A; Ferro, M; Mediate, I; Menegatti, E; Quattrocchio, G; Roccatello, D; Rollino, C | 1 |
Asano, T; Matsumoto, K; Matuzaki, G; Nomoto, K; Yoshikai, Y | 1 |
Nagasawa, K; Niho, Y; Tada, Y; Tsukamoto, H; Yamauchi, Y | 1 |
Goodwin, JS; Kucharz, EJ; Lightfoot, RW; Sierakowski, S | 1 |
Hill, GS | 1 |
Horwitz, DA; Linker-Israeli, M; Quismorio, FP | 1 |
Lomnitzer, R; Phillips, R; Rabson, AR | 1 |
Fuse, I; Hanano, M; Hattori, A; Higashihara, M; Koike, T; Nagayama, R; Shibata, A; Takahashi, H; Takeshige, T; Takizawa, S | 1 |
Cohen, PL; Eisenberg, RA; Katagiri, T; Ting, JP; Yokota, S; Yuan, D | 1 |
Binz, H; Felder, M; Fontana, A; Stolzenburg, T; Wagenhaeuser, FJ | 1 |
Crow, MK | 1 |
Murakawa, Y; Sakane, T | 1 |
Cameron, FH; Russell, PJ | 1 |
46 other study(ies) available for tetradecanoylphorbol acetate and Libman-Sacks Disease
Article | Year |
---|---|
Structural differences of neutrophil extracellular traps induced by biochemical and microbiologic stimuli under healthy and autoimmune milieus.
Topics: Biomarkers; Candida albicans; Case-Control Studies; Cathelicidins; Cathepsin G; Cells, Cultured; Extracellular Traps; Healthy Volunteers; Humans; Hypochlorous Acid; Leukocyte Elastase; Lupus Erythematosus, Systemic; Neutrophils; Peroxidase; Primary Cell Culture; Pseudomonas aeruginosa; Staphylococcus aureus; Tetradecanoylphorbol Acetate | 2021 |
Decreased Protein Kinase C-β Type II Associated with the Prominent Endotoxin Exhaustion in the Macrophage of FcGRIIb-/- Lupus Prone Mice is Revealed by Phosphoproteomic Analysis.
Topics: Animals; Cytokines; Endotoxins; Lipopolysaccharides; Lupus Erythematosus, Systemic; Macrophages; Mice, Inbred C57BL; Mice, Knockout; Phosphoproteins; Protein Kinase C beta; Proteomics; Receptors, IgG; Sepsis; Severity of Illness Index; Tetradecanoylphorbol Acetate | 2019 |
IL-22 production of effector CD4
Topics: Adult; Calcium Ionophores; Case-Control Studies; CD4-Positive T-Lymphocytes; Female; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-22; Interleukins; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Tetradecanoylphorbol Acetate | 2019 |
The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway in T-
Topics: Adult; CD27 Ligand; Cells, Cultured; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression; Humans; Immunoblotting; Ionomycin; Lupus Erythematosus, Systemic; Middle Aged; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Phosphatase 2; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate; Young Adult | 2013 |
TSPAN33 is a novel marker of activated and malignant B cells.
Topics: Animals; B-Lymphocytes; Biomarkers; Case-Control Studies; Cell Line; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Lipopolysaccharides; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Mice; Mice, Transgenic; Organ Specificity; Primary Cell Culture; Signal Transduction; Tetradecanoylphorbol Acetate; Tetraspanins | 2013 |
Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus.
Topics: Adult; Aged; Aged, 80 and over; CD11b Antigen; Escherichia coli; Flow Cytometry; Humans; Immunotherapy; L-Selectin; Lupus Erythematosus, Systemic; Male; Middle Aged; Multiple Organ Failure; Neprilysin; Neutrophils; Phagocytosis; Reactive Oxygen Species; Receptor, Anaphylatoxin C5a; Receptors, IgG; Tetradecanoylphorbol Acetate; Young Adult | 2014 |
Influence of 1 Alpha, 25-Dihydroxyvitamin D3 on T Helper 17 Cells and Related Cytokines in Systemic Lupus Erythematosus.
Topics: Adult; Brefeldin A; Calcitriol; Cells, Cultured; Female; Flow Cytometry; Humans; Interleukin-17; Interleukin-23 Subunit p19; Interleukin-6; Ionomycin; Lupus Erythematosus, Systemic; Lymphocyte Count; Male; Tetradecanoylphorbol Acetate; Th17 Cells; Transforming Growth Factor beta | 2015 |
Glucocorticoids enhance Th17/Th1 imbalance and signal transducer and activator of transcription 3 expression in systemic lupus erythematosus patients.
Topics: Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-17; Ionophores; Leukocyte Count; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Male; STAT3 Transcription Factor; Tetradecanoylphorbol Acetate; Th1 Cells; Th17 Cells | 2011 |
A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus.
Topics: Carcinogens; CD28 Antigens; CD3 Complex; Cyclic AMP Response Element Modulator; Exons; Humans; Ionomycin; Ionophores; Lupus Erythematosus, Systemic; Lymphocyte Activation; Proto-Oncogene Proteins c-fos; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Up-Regulation | 2011 |
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Cells, Cultured; Chemokine CCL2; Female; Humans; Imidazoles; Interleukin-10; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; MAP Kinase Signaling System; Middle Aged; p38 Mitogen-Activated Protein Kinases; Phytohemagglutinins; Pyridines; Receptors, Tumor Necrosis Factor; Tetradecanoylphorbol Acetate; Tumor Necrosis Factors; TWEAK Receptor; Young Adult | 2012 |
Increased expression and phosphorylation of the two S100A9 isoforms in mononuclear cells from patients with systemic lupus erythematosus: a proteomic signature for circulating low-density granulocytes.
Topics: Calgranulin B; Electrophoresis, Gel, Two-Dimensional; Granulocytes; Humans; Ionomycin; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; MAP Kinase Signaling System; Phosphorylation; Protein Isoforms; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetradecanoylphorbol Acetate | 2012 |
Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Case-Control Studies; CD5 Antigens; Humans; In Vitro Techniques; Interleukin-2; Leukocyte Common Antigens; Lupus Erythematosus, Systemic; Lymphocyte Activation; Middle Aged; Monocytes; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1989 |
Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).
Topics: Animals; Cell Adhesion; Humans; Interleukin-1; Interleukin-2; Lupus Erythematosus, Systemic; Lymphocytes; Mice; Monocytes; Rats; T-Lymphocytes, Regulatory; Tetradecanoylphorbol Acetate | 1983 |
Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus.
Topics: Adult; Cell Division; Concanavalin A; Female; Humans; Interleukin-1; Lipopolysaccharides; Lupus Erythematosus, Systemic; Lymphocyte Culture Test, Mixed; Monocytes; Rosette Formation; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1984 |
Reversal of hyporesponsiveness in lpr CD4-CD8- T cells is achieved by induction of cell cycling and normalization of CD2 and p59fyn expression.
Topics: Aged; Animals; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; CD2 Antigens; Cell Cycle; Cells, Cultured; Female; Gene Expression; Humans; In Vitro Techniques; Interleukin-2; Ionomycin; Leukocyte Common Antigens; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Mice; Mice, Mutant Strains; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Receptors, Immunologic; RNA, Messenger; T-Lymphocyte Subsets; Tetradecanoylphorbol Acetate | 1994 |
Maturational changes in CD4+ cell subsets and lymphokine production in BXSB mice.
Topics: Animals; Antigens, Surface; CD4-Positive T-Lymphocytes; CD8 Antigens; Female; Gene Expression; Interleukin-2; Ionomycin; Leukocyte Common Antigens; Lupus Erythematosus, Systemic; Lymphocyte Activation; Lymphokines; Male; Mice; Mice, Mutant Strains; Receptors, Interleukin-2; Receptors, Transferrin; RNA, Messenger; T-Lymphocyte Subsets; Tetradecanoylphorbol Acetate | 1994 |
Responsiveness of T lymphocytes from systemic lupus erythematosus to signals provided through CD26 antigen.
Topics: Adult; Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Dipeptidyl Peptidase 4; Humans; Interleukin-2; Lupus Erythematosus, Systemic; Lymphocyte Activation; Middle Aged; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1994 |
T lymphocytes from patients with systemic lupus erythematosus show increased response to interleukin-2 after costimulation with OKT3 monoclonal antibody and phorbol esters.
Topics: Adult; Humans; Interleukin-2; Lupus Erythematosus, Systemic; Lymphocyte Activation; Middle Aged; Muromonab-CD3; Receptors, Interleukin-2; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1994 |
Aberrant expression of the very early activation antigen on MRL/Mp-lpr/lpr lymphocytes.
Topics: Age Factors; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; CD4 Antigens; CD8 Antigens; Cricetinae; Lectins, C-Type; Lupus Erythematosus, Systemic; Lymphocyte Activation; Lymphoproliferative Disorders; Mice; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1993 |
The secretion of the third component of complement (C3) by human polymorphonuclear leucocytes from both normal and systemic lupus erythematosus cases.
Topics: Cells, Cultured; Complement C3; Humans; Immunoenzyme Techniques; Lupus Erythematosus, Systemic; Neutrophils; Protein Kinase C; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1993 |
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
Topics: Adult; Aged; B7-1 Antigen; CD40 Antigens; CD40 Ligand; Female; Humans; Ionomycin; Ligands; Lupus Erythematosus, Systemic; Lymphocyte Activation; Lymphocytes; Male; Membrane Glycoproteins; Middle Aged; Tetradecanoylphorbol Acetate | 1996 |
Hyperproliferation of BXSB B cells is linked to the Yaa allele.
Topics: Alleles; Animals; Antibodies, Anti-Idiotypic; B-Lymphocytes; Disease Models, Animal; Genetic Linkage; Immunoglobulin M; Ionomycin; Lipopolysaccharides; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Spleen; Tetradecanoylphorbol Acetate; Time Factors | 1996 |
Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus.
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Calcimycin; Calcium; Carcinogens; Cell Division; Cytosol; Enzyme Inhibitors; Female; Flow Cytometry; Humans; Hydrogen-Ion Concentration; Interleukin-2; Intracellular Fluid; Ionophores; Lectins, C-Type; Lupus Erythematosus, Systemic; Lymphocyte Activation; Protein Kinase C; Sodium-Hydrogen Exchangers; Spectrometry, Fluorescence; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thapsigargin | 1997 |
Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus.
Topics: Adult; Cells, Cultured; Female; Flow Cytometry; Humans; Interferon-gamma; Interleukins; Ionomycin; Lupus Erythematosus, Systemic; Lymphocyte Activation; Middle Aged; Monensin; Tetradecanoylphorbol Acetate; Th1 Cells; Th2 Cells | 1998 |
Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells.
Topics: Adult; B-Lymphocytes; Cell Line, Transformed; Estradiol; Female; Humans; Ionomycin; Lupus Erythematosus, Systemic; Monocytes; Polymerase Chain Reaction; Receptors, Estrogen; RNA, Messenger; Sequence Analysis; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1998 |
Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus.
Topics: Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Case-Control Studies; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Interleukin-10; Intracellular Fluid; Lectins, C-Type; Lupus Erythematosus, Systemic; Lymphocyte Activation; Lymphocytes; Recombinant Proteins; Sodium-Hydrogen Exchangers; Tetradecanoylphorbol Acetate | 1998 |
Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus.
Topics: Abatacept; Antigens, CD; Antigens, Differentiation; Antigens, Surface; CTLA-4 Antigen; Female; Humans; Immunoconjugates; Ionomycin; Kinetics; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Male; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Tetradecanoylphorbol Acetate; Up-Regulation | 1998 |
Procainamide, a drug causing lupus, induces prostaglandin H synthase-2 and formation of T cell-sensitizing drug metabolites in mouse macrophages.
Topics: Animals; Arylamine N-Acetyltransferase; Enzyme Induction; Female; Isoenzymes; Lupus Erythematosus, Systemic; Lymph Nodes; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Procainamide; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1999 |
Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
Topics: Autoradiography; Calcimycin; DNA-Binding Proteins; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Humans; Kinetics; Lupus Erythematosus, Systemic; Lymphocyte Activation; NF-kappa B; NF-kappa B p50 Subunit; Normal Distribution; Receptors, Antigen, T-Cell; Severity of Illness Index; T-Lymphocytes; Tetradecanoylphorbol Acetate; Time Factors; Transcription Factor RelA | 1999 |
[Free radicals and reduced DNA damage in repair-defective human cells].
Topics: Case-Control Studies; DNA Damage; DNA Repair; Humans; In Vitro Techniques; Luminescent Measurements; Lupus Erythematosus, Systemic; Reactive Oxygen Species; Tetradecanoylphorbol Acetate | 1999 |
Glucocorticosteroid dependent decrease in the activity of calcineurin in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Calcineurin; Case-Control Studies; Cells, Cultured; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Ionophores; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Tetradecanoylphorbol Acetate | 2001 |
Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.
Topics: Animals; Arteriosclerosis; Calcium; Cell Cycle Proteins; Cell Line; Chemotaxis, Leukocyte; Humans; Jurkat Cells; Ligands; Lupus Erythematosus, Systemic; Lymphocyte Activation; Lysophosphatidylcholines; Mitogen-Activated Protein Kinases; Phosphorylcholine; Radioligand Assay; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Signal Transduction; Sphingosine; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transfection; Virulence Factors, Bordetella | 2001 |
The effects of hormonal and other stimuli on cell-surface Ro/SSA antigen expression by human keratinocytes in vitro: their possible role in the induction of cutaneous lupus lesions.
Topics: Antigens, Surface; Autoantigens; Cells, Cultured; Cholera Toxin; Cytokines; Estradiol; Female; Humans; Hydrogen Peroxide; Keratinocytes; Leukotriene B4; Lupus Erythematosus, Systemic; Ribonucleoproteins; RNA, Small Cytoplasmic; Sex Factors; Tetradecanoylphorbol Acetate; Ultraviolet Rays | 1992 |
Effects of ANCA-positive sera on the generation of oxygen free radicals by neutrophils.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Female; Humans; In Vitro Techniques; Luminescent Measurements; Lupus Erythematosus, Systemic; Neutrophils; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Vasculitis | 1992 |
Subpopulations of CD4+ cells in lpr/lpr mice: differences in expression of T cell receptor/CD3 complex and proliferative responses.
Topics: Animals; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Blotting, Northern; Calcimycin; CD3 Complex; CD4 Antigens; CD4-Positive T-Lymphocytes; Flow Cytometry; Gene Expression; Interleukin-2; Leukocyte Common Antigens; Lupus Erythematosus, Systemic; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Mutant Strains; Receptors, Antigen, T-Cell; RNA, Messenger; Tetradecanoylphorbol Acetate | 1990 |
A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus.
Topics: Biological Transport, Active; Cell Division; Cells, Cultured; Cytosol; Female; Humans; In Vitro Techniques; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Phosphorylation; Phytohemagglutinins; Protein Kinase C; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1991 |
Impaired T-cell activation in patients with systemic lupus erythematosus.
Topics: Adult; Calcimycin; Calcium; Cell Separation; Cells, Cultured; Female; Humans; Interleukin-2; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Middle Aged; Phytohemagglutinins; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1989 |
Drug-associated glomerulopathies.
Topics: Amyloidosis; Animals; Captopril; Cyclosporins; Disease Models, Animal; Gold; Heroin Dependence; Humans; Hydrocarbons; Immune Complex Diseases; Kidney Diseases; Kidney Glomerulus; Lupus Erythematosus, Systemic; Mercury; Nephrotic Syndrome; Penicillamine; Puromycin Aminonucleoside; Serum Sickness; Solvents; Tetradecanoylphorbol Acetate | 1986 |
Further characterization of interleukin-2 production by lymphocytes of patients with systemic lupus erythematosus.
Topics: Adult; Antigens, Differentiation; Female; Humans; Interleukin-2; Lupus Erythematosus, Systemic; Monocytes; Phytohemagglutinins; Receptors, Interleukin-2; Reference Values; T-Lymphocytes, Regulatory; Tetradecanoylphorbol Acetate | 1988 |
Modulation of the sodium periodate (NaIO4) response in systemic lupus erythematosus (SLE): effect of interleukin-1 (IL-1), interleukin-2 (IL-2), phorbol myristate acetate (PMA), and indomethacin.
Topics: Female; Humans; Indomethacin; Interleukin-1; Interleukin-2; Lupus Erythematosus, Systemic; Male; Mitogens; Neutrophils; Periodic Acid; Phorbols; Tetradecanoylphorbol Acetate | 1985 |
A defect of platelet release reaction in a patient with SLE: impaired platelet aggregation induced by phorbol ester with a normal phosphorylation of 40K protein.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Blood Proteins; Calcimycin; Collagen; Diglycerides; Epinephrine; Female; Humans; Lupus Erythematosus, Systemic; Phorbols; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Tetradecanoylphorbol Acetate; Thrombin | 1986 |
The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
Topics: Animals; Antigens, Differentiation, T-Lymphocyte; Calcimycin; Gene Expression Regulation; Interleukin-2; Lupus Erythematosus, Systemic; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Mutant Strains; Proto-Oncogene Proteins; Proto-Oncogenes; Receptors, Immunologic; Receptors, Interleukin-2; RNA, Messenger; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transcription, Genetic | 1987 |
Impaired mitogen-induced interferon-gamma production in rheumatoid arthritis and related diseases.
Topics: Adolescent; Adult; Aged; Arthritis, Reactive; Arthritis, Rheumatoid; Autoimmune Diseases; Calcimycin; Drug Synergism; Humans; Interferon-gamma; Lectins; Lupus Erythematosus, Systemic; Lymphocyte Activation; Middle Aged; Osteoarthritis; Receptors, Immunologic; Receptors, Interleukin-2; Scleroderma, Systemic; Tetradecanoylphorbol Acetate | 1988 |
Enhancement of the impaired autologous mixed leukocyte reaction in patients with systemic lupus erythematosus.
Topics: Adult; Cell Division; Female; Formaldehyde; Histocompatibility Antigens Class II; Humans; Lupus Erythematosus, Systemic; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Middle Aged; Staphylococcus aureus; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thymidine | 1985 |
Deficient phytohemagglutinin-induced interleukin-2 activity in patients with inactive systemic lupus erythematosus is correctable by the addition of phorbol myristate acetate.
Topics: Adult; Biomechanical Phenomena; Ethers; Female; Humans; Interleukin-2; Ionomycin; Lupus Erythematosus, Systemic; Phytohemagglutinins; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1988 |
Studies of macrophage function in murine systemic lupus erythematosus. 4. Failure to reverse the defect in Fc-mediated phagocytosis and binding by in vitro stimulants or prostaglandins.
Topics: Animals; Bone Marrow Cells; Indomethacin; Lupus Erythematosus, Systemic; Lymphokines; Macrophages; Mice; Mice, Inbred Strains; Phagocytosis; Prostaglandins; Receptors, Fc; Tetradecanoylphorbol Acetate; Tretinoin | 1986 |